MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study

Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia

(2014) K. A. Davis et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Novel missense MTTP gene mutations causing abetalipoproteinemia

(2014) Sharon A. Miller et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lomitapide and Mipomersen

(2014) Daniel J. Rader et al.   CIRCULATION

Hypobetalipoproteinemia and abetalipoproteinemia

(2014) Francine K. Welty   CURRENT OPINION IN LIPIDOLOGY

MTP −493G>T Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease: A Meta-Analysis

(2014) Wei Zheng et al.   DNA AND CELL BIOLOGY

Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

(2014) Minjie Lin et al.   DRUG SAFETY

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

(2014) Mathilde Di Filippo et al.   JOURNAL OF HEPATOLOGY

Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice

(2014) Arne Dikkers et al.   JOURNAL OF LIPID RESEARCH

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

(2013) Amirhossein Sahebkar et al.   CLINICAL THERAPEUTICS

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

(2013) Yuki Kawano et al.   JOURNAL OF GASTROENTEROLOGY

Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia

(2013) Irani Khatun et al.   JOURNAL OF LIPID RESEARCH

Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

(2013) Gregory S. Thomas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

MTTPpolymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population

(2013) Xian E. Peng et al.   LIVER INTERNATIONAL

Lumenal Lipid Metabolism

(2012) Richard Lehner et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

(2012) G. Musso et al.   DIABETOLOGIA

Multiple functions of microsomal triglyceride transfer protein

(2012) M Mahmood Hussain et al.   Nutrition & Metabolism

Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice

(2011) Irani Khatun et al.   HEPATOLOGY

SDM--a server for predicting effects of mutations on protein stability and malfunction

(2011) C. L. Worth et al.   NUCLEIC ACIDS RESEARCH

Allele-specific regulation ofMTTPexpression influences the risk of ischemic heart disease

(2009) Anna Aminoff et al.   JOURNAL OF LIPID RESEARCH

Lipoprotein metabolism mediates the association of MTP polymorphism with β-cell dysfunction in healthy subjects and in nondiabetic normolipidemic patients with nonalcoholic steatohepatitis

(2009) Giovanni Musso et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The influence of polymorphism of −493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress

(2008) Aleš Žák et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

MTTP variants and body mass index, waist circumference and serum cholesterol level: Association analyses in 7582 participants of the KORA study cohort

(2008) Mike Böhme et al.   MOLECULAR GENETICS AND METABOLISM

Abetalipoproteinemia: two case reports and literature review

(2008) Rola Zamel et al.   Orphanet Journal of Rare Diseases